5-Bromo-6-fluoropyridin-2-amine, 95.0%, 1g

2-(N-cyclopropylcarbamoyl)cyclohexanecarboxylic acid, 97%, 10g

5-Amino-4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridine carboxamide, 95.0%, 1g

5-amino-N-methyl-1H-pyrazole-3-carboxamide hydrochloride, 95.0%, 250mg

(4S,5S)-4,5-Diphenyl-2-(quinolin-2-yl)-4,5-dihydrooxazole, 98%, 5g

Sodium bismuthate dihydrate, min. 99%, pa, 100 g, plastic packaging.

Single-channel microliter pipette Acura® manual XS 826, 2 to 20 µl, 1 piece

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrido[2,3-b]pyrazine, 95+%, 100mg

tert-Butyl (2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate, 95.0%, 1g

3-Phosphonobenzoic acid, 98%, 50mg

(E)-4'-Chloro-4-methoxychalcone>98.0%(GC)1g

Bromotriphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-lambda5-phosphane, 98+%, 1g

N-(4-sec-butylphenyl)-3-chloropropanamide, 95.0%, 5g